Replies to post #193100 on Biotech Values

[DewDiligence]

OFIX acquires SPNE for $7.66*/sh in stock—a 38%* premium to yesterday’s close—in deal billed as a “merger of equals”:

https://www.businesswire.com/news/home/20221011005510/en/

The nominal deal value is $306M.

SPNE is a 2015 spin-off from IART (#msg-115100324).

*Based on OFIX’s closing price of $18.40 yesterday.